Core Viewpoint - Intelligent Bio Solutions Inc. is expanding its Intelligent Fingerprinting Drug Screening System to include Latin American Spanish, addressing the growing demand in Spanish-speaking markets and enhancing accessibility for over 4 billion potential users worldwide [1][4]. Company Developments - The integration of Latin American Spanish into the System is part of a major multilingual upgrade aimed at improving usability across diverse international settings [1][4]. - The Company has over 400 accounts across 19 countries and is preparing to enter the multi-billion-dollar U.S. market following its FDA 510(k) submission in December 2024 [4]. Market Insights - The Latin American drug screening market is projected to reach USD 1.1 billion by 2030, driven by increasing public safety initiatives and workplace compliance programs [3]. - Spain's drug testing market is expected to reach USD 368.4 million by 2030, reflecting similar trends in regulation and adoption [3]. Strategic Growth - The enhancement of the System to support Latin American Spanish strengthens the Company's position in Spanish-speaking markets and aligns with its strategic growth plans [2][3]. - The multilingual capabilities of the System are seen as a key differentiator in the market, providing local language support that many competitors do not offer [3].